Effects of anesthetic agents on cellular 123I-MIBG transport and in vivo 123I-MIBG biodistribution

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 3, 2008, Pages 554-561

  Ko, Bong Ho ^a   Paik, Jin Young ^a   Jung, Kyung Ho ^a   Bae, Jun Sang ^a   Lee, Eun Jung ^a   Choe, Yearn Seong ^a   Kim, Byung Tae ^a   Lee, Kyung Han ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

123I MIBG; Anesthesia; Myocardium; Norepinephrine; Transporter; Tumor

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ANESTHETIC AGENT; KETAMINE; LEAD; PENTOBARBITAL; XYLAZINE;

ANESTHESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISTRIBUTION; DRUG INHIBITION; DRUG TRANSPORT; HUMAN; HUMAN CELL; MOUSE; NEUROBLASTOMA; NONHUMAN; PHEOCHROMOCYTOMA; RAT; WESTERN BLOTTING;

3-IODOBENZYLGUANIDINE; ANESTHETICS; ANIMALS; CELL LINE, TUMOR; DRUG INTERACTIONS; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED BALB C; MICE, INBRED ICR; MICE, NUDE; NEUROBLASTOMA; ORGAN SPECIFICITY; PHEOCHROMOCYTOMA; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION;

EID: 43349087641     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-007-0605-0     Document Type: Article

References (21)

1. 18F-FDG biodistribution and insulin levels in tumor-bearing mice. J Nucl Med 2005;46:1531-6.
2. 18F-FDG PET studies in mice. J Nucl Med 2006;47:999-1006.
3. 131I-MIBG) in an animal model of neuroblastoma. Pediatr Radiol 2003;33:688-92.
4. 125I] metaiodobenzylguanidine therapy in macroscopic and microscopic tumors: a comparative study in SK-N-SH human neuroblastoma and PC12 rat pheochromocytoma xenografts. Int J Cancer 2000;90:312-25.
5. Rutgers M, Buitenhuis CK, Hoefnagel CA. Targeting of meta- iodobenzylguanidine to SK-N-SH human neuroblastoma xenografts: tissue distribution, metabolism and therapeutic efficacy. Int J Cancer 2000;87:412-22.
6. Anton M, Wagner B, Haubner R, Bodenstein C, Essien BE, Bonisch H, et al. Use of the norepinephrine transporter as a reporter gene for non-invasive imaging of genetically modified cells. J Gene Med 2004;6:119-26.
7. 124I-MIBG. Nucl Med 2007;48:827-36.
8. Nishimura M, Sato K, Okada T. Ketamine inhibits monoamine transporters expressed in human embryonic kidney 293 cells. Anesthesiology 1998;88:768-74.
9. Hara K, Yanagihara N, Minami K. Ketamine interacts with the noradrenaline transporter at a site partly overlapping the desipramine binding site. Naunyn Schmiedebergs Arch Pharmacol 1998;358:328-33.
10. Shahani SK, Lingamaneni R, Hemmings HC Jr. General anesthetic actions on norepinephrine, dopamine, and gamma-aminobutyric acid transporters in stably transfected cells. Anesth Analg 2002;95:893-9.
11. Salt PJ, Barnes PK, Beswick FJ. Inhibition of neuronal and extraneuronal uptake of noradrenaline by ketamine in the isolated perfused rat heart. Br J Anaesth 1979;51:835-8.
12. Maignan E, Dong WX, Legrand M. Sympathetic activity in the rat: effects of anaesthesia on noradrenaline kinetics. J Auton Nerv Syst 2000;80:46-51.
13. Matsukawa K, Ninomiya I, Nishiura N. Effects of anesthesia on cardiac and renal sympathetic nerve activities and plasma catecholamines. Am J Physiol 1994;265:R792-7.
14. Appel E, Dudziak R, Palm D, Wnuk A. Sympathoneuronal and sympathoadrenal activation during ketamine anesthesia. Eur J Clin Pharmacol 1979;16:91-5.
15. Franks NP, Lieb WR. Molecular and cellular mechanisms of general anaesthesia. Nature 1994;367:607-14.
16. Kaka JS, Hayton WL. Pharmacokinetics of ketamine and two metabolites in the dog. J Pharmacokinet Biopharm 1980;8:193-202.
17. Rector E, Otto K, Kietzmann M, Nolte I, Lehmacher W. Pharmacokinetics and effects of xylazine (Rompun) in dogs. Berl Munch Tierarztl Wochenschr 1996;109:18-22.
18. 123I-MIBG kinetics in rats. J Nucl Med 1999;40:2088-93.
19. Burchardi H, Kaczmarczyk G. The effect of anaesthesia on renal function. Eur J Anaesthesiol 1994;11:163-8.
20. Ambrisko TD, Hikasa Y. Neurohormonal and metabolic effects of medetomidine compared with xylazine in beagle dogs. Can J Vet Res 2002;66:42-9.
21. Ho CM, Su CK. Ketamine attenuates sympathetic activity through mechanisms not mediated by N-methyl-D-aspartate receptors in the isolated spinal cord of neonatal rats. Anesth Analg 2006;102:806-10.